Developer docs
API playgroundTry for free, no card

Search company profiles

Real Life Sciences

Full company profile

uuid0009cno

Namestring
Real Life Sciences
Legal namestring
Real Life Sciences, LLC
Websiteurl
rlsciences.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

Real Life Sciences (RLS) is a clinical trial anonymization and redaction technology company serving pharmaceutical sponsors and contract research organizations (CROs) that must comply with global clinical trial transparency regulations. Founded circa 2018 and headquartered in Wayne, Pennsylvania, with an operations arm in Mandaluyong, Philippines, the company was acquired by MediSpend in January 2025 and continues to operate under the RLS brand as a subsidiary. RLS's core offering is the RLS Protect platform, an NLP-based SaaS solution purpose-built for life sciences disclosure workflows; modules cover data anonymization with quantitative risk modeling (including Health Canada's 0.09 re-identification threshold and EMA Policy 0070), document redaction, and Confidential Information Management (CIM), with integrations between AI-driven redaction suggestions and CIM workflows. The platform is supported by the Anonymization Services managed services arm, a full-time delivery team that uses the proprietary technology and a documented track record of 1M+ pages and thousands of datasets processed across regulatory and voluntary submissions.

RLS monetizes through multi-year SaaS subscriptions (RLS Protect) plus hybrid managed services engagements and professional services — including regulatory meeting preparation (e.g., Health Canada PIM), methodology training, and SAS training — aligning engagement models (dedicated, pooled, or custom teams) to sponsor and CRO priorities. Primary customers are pharmaceutical sponsors handling EMA Policy 0070, Health Canada PRCI, EMA CTR/CTIS, and FDA disclosure work, with CROs as a second primary segment using RLS Protect to serve their sponsor clients; non-profit research organizations (e.g., Vivli) make up a smaller tertiary segment supported via grant-funded partnerships, including with the Bill & Melinda Gates Foundation. GTM is direct enterprise sales with relationship-based engagement across regulatory, transparency, and compliance stakeholders, complemented by a content-driven thought-leadership engine (insights blog, webinars, podcasts) and ecosystem partnerships with Citeline (data intelligence) and ClaritiDox (regulatory writing). The company holds ISO/IEC 27001:2022 certification covering product development, managed service operations, customer success and support, and application hosting, which functions as enterprise procurement gating.

Short descriptiontext

Real Life Sciences is a clinical trial anonymization and redaction technology company that provides its NLP-based RLS Protect SaaS platform and managed Anonymization Services to pharmaceutical sponsors and CROs for global regulatory disclosure compliance (EMA, Health Canada, FDA).

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersWayne, United States
HQ citystring
Wayne
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial anonymization, regulatory disclosure software, document redaction solution, confidential information management, life sciences compliance
Industry4 codes
PRIMARYHLACAOAM
Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGAAAK
Real-World Evidence (RWE), HEOR & Epidemiology CROs
SECONDARYBPAHALAN
Healthcare Outcomes & Real-World Evidence (RWE) Analytics
SECONDARYHLAGAJAF
Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
NAICS code2 codes
  • Software Publishers513210
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Trial Disclosure & Data Anonymization Software
Social media profiles1 record
Revenue model3 records
1SaaS Subscription (RLS Protect)
TypeSubscription Recurring
Description

Software-as-a-service subscription model providing access to RLS Protect platform for data and document anonymization and redaction. Customers can use the technology independently after onboarding and training.

rlsciences.com
2Anonymization Services
TypeManaged Services
Description

Managed services offering where RLS's full-time staff handles anonymization and redaction projects on-time and on-quality. Offers flexible engagement models including dedicated resources, pooled resources, or custom team configurations.

rlsciences.com
3Professional Services
TypeProfessional Services
Description

Turnkey project management and consulting services including regulatory meeting preparation (e.g., Health Canada PIM meetings), methodology training, and SaaS training to enable client teams.

rlsciences.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details2 tiers
1SaaS Model - Self-service platform access with training and support
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Organizations can license RLS Protect platform and handle anonymization internally after receiving methodology and application training from RLS.

rlsciences.com
2Managed Services Model - Full-service anonymization delivery
ModelHybridBilling cadenceMulti-year contract
Notes

RLS team handles day-to-day project tasks while working hand-in-glove with sponsor to review and approve anonymization strategy. Dedicated team options available for high-volume customers.

rlsciences.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 5 records shown
1RLS Protect
Description

Leading data and document anonymization and redaction solution for Sponsors and CROs who comply with transparency requirements for regulatory bodies and voluntary sharing initiatives

rlsciences.com
+4 more records
Core offering1 text field

Real Life Sciences develops and sells the RLS Protect SaaS platform for clinical trial data anonymization and document redaction, supporting pharmaceutical sponsors and CROs in complying with global transparency regulations including EMA Policy 0070, Health Canada PRCI, EMA (EU) 536/2014/CTIS, and FDA disclosures. The platform combines NLP-based quantitative risk modeling, document redaction, and confidential information management, and is paired with Anonymization Services (managed service delivery) and the RLS Reveal real-world evidence discovery platform. The portfolio serves clients ranging from small trials to large global pharma, with over one million pages and thousands of datasets processed to date.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Successfully processed over 1 million pages and thousands of datasets for regulatory and voluntary submissions
+3 more records
Product overview1 text field

Real Life Sciences offers a unified platform-plus-services portfolio centered on RLS Protect, their SaaS-based anonymization and redaction solution for clinical trial disclosure. The core RLS Protect platform encompasses modules for data anonymization, document redaction, and confidential information management (CIM), all built on NLP technology. The portfolio also includes RLS Reveal, a real-world evidence discovery platform, and Anonymization Services—a managed services offering staffed by full-time experts who use the proprietary RLS Protect technology to deliver turnkey anonymization projects. The products serve pharmaceutical sponsors and CROs across regulatory disclosure requirements including Health Canada PRCI, EMA Policy 0070, EMA CTR/CTIS, and voluntary data sharing initiatives.

Product and service6 records
1RLS Protect
CategoryClinical Trial Disclosure Software (SaaS)
Description

RLS Protect is a SaaS-based data and document anonymization and redaction solution designed for pharmaceutical sponsors and CROs. It offers advanced quantitative risk modeling, document anonymization, and redaction capabilities supporting Health Canada PRCI, EMA Policy 0070, EMA (EU) 536/2014/CTIS, FDA disclosures, and voluntary data sharing initiatives.

2RLS Protect - Redaction
CategoryDocument Redaction Software
Description

Document redaction capability within the RLS Protect platform that enables organizations to efficiently redact personal and confidential information from clinical documents while maintaining compliance with transparency requirements.

3RLS Protect - Confidential Information Management (CIM)
CategoryConfidential Information Management Software
Description

Central solution within RLS Protect for identifying, reviewing, and redacting confidential information across teams. Features include confidential asset tracking, automated approval workflows, public domain scanning, AI-driven redaction integration, and audit-ready logs to protect IP and trade secrets.

4RLS Protect - Anonymization
CategoryData Anonymization Software
Description

Core anonymization module within the RLS Protect platform providing quantitative risk-based anonymization strategies for clinical trial data and documents, enabling measurement of re-identification risk and data utility for regulatory submissions.

5Anonymization Services
CategoryManaged Anonymization Services
Description

Managed-service offering providing full-time operational staff who use proprietary RLS technology and methodology to deliver anonymization and redaction projects on-time and on-quality for sponsors and CROs. Services include project management, risk assessment, document processing, and regulatory submission support, with flexible engagement models (dedicated, pooled, or custom teams).

6RLS Reveal
CategoryReal-World Evidence Analytics Software
Description

Real-world data/evidence discovery platform that processes data from disparate sources such as social media using NLP and machine learning, producing analytics around patient-reported outcomes and real-world evidence for life sciences organizations.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Vivli is a non-profit organization home to an independent global data-sharing and analytics platform serving the international research community. RLS collaborates with Vivli to provide anonymization services for clinical trials, with Vivli acting as a neutral broker between data contributor and data user.

Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

ClaritiDox is a team of experienced regulatory writers, editors, health literacy experts, and data anonymization specialists. They are recognized as a public benefit company promoting responsible sharing of study information. Partnership provides complementary document preparation and disclosure expertise.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers6 records
TypeBroad incumbent
Description

Veeva is a major clinical and regulatory SaaS platform for life sciences, with Veeva Vault covering trial management, regulatory submissions, and quality — a broad incumbent that can bundle disclosure and anonymization features.

TypeDirect peer
Description

TrialScope provides clinical trial disclosure, transparency, and data-sharing solutions to sponsors and CROs, competing with RLS in the EMA/FDA disclosure and trial registration space.

3d-wise
TypeDirect peer
Description

d-wise provides clinical data standards, analytics, and anonymization services for life sciences R&D, sharing RLS's focus on CDISC-aligned clinical trial data and regulatory submission support.

TypeDirect peer
Description

Acquired by IQVIA, Privacy Analytics provides health data de-identification and anonymization software for clinical trials and health data sharing — directly comparable to RLS Protect's quantitative risk-based anonymization capability.

5SHYFT Analytics (Veeva)
TypeDirect peer
Description

SHYFT was acquired by Veeva and provides clinical and commercial data analytics including disclosure and transparency solutions for pharma, overlapping with RLS's regulatory disclosure focus.

6Oracle Health Sciences
TypeBroad incumbent
Description

Oracle offers EDC (InForm), CTMS, safety, and analytics for clinical development; a broad incumbent that competes across the clinical trial technology stack and could expand into disclosure/redaction.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Real Life Sciences

Clinical Trial Disclosure & Data Anonymization Softwarerlsciences.com

Real Life Sciences is a clinical trial anonymization and redaction technology company that provides its NLP-based RLS Protect SaaS platform and managed Anonymization Services to pharmaceutical sponsors and CROs for global regulatory disclosure compliance (EMA, Health Canada, FDA).

What Real Life Sciences does

Real Life Sciences (RLS) is a clinical trial anonymization and redaction technology company serving pharmaceutical sponsors and contract research organizations (CROs) that must comply with global clinical trial transparency regulations. Founded circa 2018 and headquartered in Wayne, Pennsylvania, with an operations arm in Mandaluyong, Philippines, the company was acquired by MediSpend in January 2025 and continues to operate under the RLS brand as a subsidiary. RLS's core offering is the RLS Protect platform, an NLP-based SaaS solution purpose-built for life sciences disclosure workflows; modules cover data anonymization with quantitative risk modeling (including Health Canada's 0.09 re-identification threshold and EMA Policy 0070), document redaction, and Confidential Information Management (CIM), with integrations between AI-driven redaction suggestions and CIM workflows. The platform is supported by the Anonymization Services managed services arm, a full-time delivery team that uses the proprietary technology and a documented track record of 1M+ pages and thousands of datasets processed across regulatory and voluntary submissions.

RLS monetizes through multi-year SaaS subscriptions (RLS Protect) plus hybrid managed services engagements and professional services — including regulatory meeting preparation (e.g., Health Canada PIM), methodology training, and SAS training — aligning engagement models (dedicated, pooled, or custom teams) to sponsor and CRO priorities. Primary customers are pharmaceutical sponsors handling EMA Policy 0070, Health Canada PRCI, EMA CTR/CTIS, and FDA disclosure work, with CROs as a second primary segment using RLS Protect to serve their sponsor clients; non-profit research organizations (e.g., Vivli) make up a smaller tertiary segment supported via grant-funded partnerships, including with the Bill & Melinda Gates Foundation. GTM is direct enterprise sales with relationship-based engagement across regulatory, transparency, and compliance stakeholders, complemented by a content-driven thought-leadership engine (insights blog, webinars, podcasts) and ecosystem partnerships with Citeline (data intelligence) and ClaritiDox (regulatory writing). The company holds ISO/IEC 27001:2022 certification covering product development, managed service operations, customer success and support, and application hosting, which functions as enterprise procurement gating.

Real Life Sciences firmographics

Firmographics
Name
Real Life Sciences
Legal name
Real Life Sciences, LLC
Website
https://rlsciences.com
Company type
Private
Founded year
2018
Operating status
Acquired
Headcount range
51–100 employees
Short description
Real Life Sciences is a clinical trial anonymization and redaction technology company that provides its NLP-based RLS Protect SaaS platform and managed Anonymization Services to pharmaceutical sponsors and CROs for global regulatory disclosure compliance (EMA, Health Canada, FDA).
Ownership category
akta.pro rank

Real Life Sciences industry classification

Industry
Product category
Clinical Trial Disclosure & Data Anonymization Software
NAICS
Software Publishers (513210), Scientific Research and Development Services (5417)
SIC
Services-Prepackaged Software (7372), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLACAOAM
Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGAAAK
Real-World Evidence (RWE), HEOR & Epidemiology CROs
SECONDARYBPAHALAN
Healthcare Outcomes & Real-World Evidence (RWE) Analytics
SECONDARYHLAGAJAF
Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

  • Clinical trial anonymization
  • Regulatory disclosure software
  • Document redaction solution
  • Confidential information management
  • Life sciences compliance

Where Real Life Sciences is headquartered

Location

Headquarters

HQ city
Wayne
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Real Life Sciences business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. SaaS Subscription (RLS Protect): Software-as-a-service subscription model providing access to RLS Protect platform for data and document anonymization and redaction. Customers can use the technology independently after onboarding and training.
  2. Anonymization Services: Managed services offering where RLS's full-time staff handles anonymization and redaction projects on-time and on-quality. Offers flexible engagement models including dedicated resources, pooled resources, or custom team configurations.
  3. Professional Services: Turnkey project management and consulting services including regulatory meeting preparation (e.g., Health Canada PIM meetings), methodology training, and SaaS training to enable client teams.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractSaaS Model - Self-service platform access with training and support
HybridMulti-year contractManaged Services Model - Full-service anonymization delivery

Distribution channels1 record

Marketing channels6 records

Real Life Sciences product offering

Product offering

Core offering

Real Life Sciences develops and sells the RLS Protect SaaS platform for clinical trial data anonymization and document redaction, supporting pharmaceutical sponsors and CROs in complying with global transparency regulations including EMA Policy 0070, Health Canada PRCI, EMA (EU) 536/2014/CTIS, and FDA disclosures. The platform combines NLP-based quantitative risk modeling, document redaction, and confidential information management, and is paired with Anonymization Services (managed service delivery) and the RLS Reveal real-world evidence discovery platform. The portfolio serves clients ranging from small trials to large global pharma, with over one million pages and thousands of datasets processed to date.

Product overview

Real Life Sciences offers a unified platform-plus-services portfolio centered on RLS Protect, their SaaS-based anonymization and redaction solution for clinical trial disclosure. The core RLS Protect platform encompasses modules for data anonymization, document redaction, and confidential information management (CIM), all built on NLP technology. The portfolio also includes RLS Reveal, a real-world evidence discovery platform, and Anonymization Services—a managed services offering staffed by full-time experts who use the proprietary RLS Protect technology to deliver turnkey anonymization projects. The products serve pharmaceutical sponsors and CROs across regulatory disclosure requirements including Health Canada PRCI, EMA Policy 0070, EMA CTR/CTIS, and voluntary data sharing initiatives.

Differentiator

Problem solved

Functional benefit

Brands

  • RLS Protect: Leading data and document anonymization and redaction solution for Sponsors and CROs who comply with transparency requirements for regulatory bodies and voluntary sharing initiatives
  • RLS Reveal
  • RLS Protect CIM
  • RLS Protect Redaction
  • Anonymization Services

Products and services

  • RLS Protect RLS Protect is a SaaS-based data and document anonymization and redaction solution designed for pharmaceutical sponsors and CROs. It offers advanced quantitative risk modeling, document anonymization, and redaction capabilities supporting Health Canada PRCI, EMA Policy 0070, EMA (EU) 536/2014/CTIS, FDA disclosures, and voluntary data sharing initiatives.
  • RLS Protect - Redaction Document redaction capability within the RLS Protect platform that enables organizations to efficiently redact personal and confidential information from clinical documents while maintaining compliance with transparency requirements.
  • RLS Protect - Confidential Information Management (CIM) Central solution within RLS Protect for identifying, reviewing, and redacting confidential information across teams. Features include confidential asset tracking, automated approval workflows, public domain scanning, AI-driven redaction integration, and audit-ready logs to protect IP and trade secrets.
  • RLS Protect - Anonymization Core anonymization module within the RLS Protect platform providing quantitative risk-based anonymization strategies for clinical trial data and documents, enabling measurement of re-identification risk and data utility for regulatory submissions.
  • Anonymization Services Managed-service offering providing full-time operational staff who use proprietary RLS technology and methodology to deliver anonymization and redaction projects on-time and on-quality for sponsors and CROs. Services include project management, risk assessment, document processing, and regulatory submission support, with flexible engagement models (dedicated, pooled, or custom teams).
  • RLS Reveal Real-world data/evidence discovery platform that processes data from disparate sources such as social media using NLP and machine learning, producing analytics around patient-reported outcomes and real-world evidence for life sciences organizations.

Quantifiable outcome

  • Successfully processed over 1 million pages and thousands of datasets for regulatory and voluntary submissions
  • +3 more outcomes

Companies that use Real Life Sciences

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Real Life Sciences technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature6 records

Real Life Sciences partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and minor.

  • VivlicoreStrategic or Co-development PartnerVivli is a non-profit organization home to an independent global data-sharing and analytics platform serving the international research community. RLS collaborates with Vivli to provide anonymization services for clinical trials, with Vivli acting as a neutral broker between data contributor and data user.
  • ClaritiDoxminorImplementation/ SI/ Consulting PartnerClaritiDox is a team of experienced regulatory writers, editors, health literacy experts, and data anonymization specialists. They are recognized as a public benefit company promoting responsible sharing of study information. Partnership provides complementary document preparation and disclosure expertise.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Real Life Sciences competitors and assessment

Company assessment

Broad incumbents

  • Veeva Systems: Veeva is a major clinical and regulatory SaaS platform for life sciences, with Veeva Vault covering trial management, regulatory submissions, and quality — a broad incumbent that can bundle disclosure and anonymization features.
  • Oracle Health Sciences: Oracle offers EDC (InForm), CTMS, safety, and analytics for clinical development; a broad incumbent that competes across the clinical trial technology stack and could expand into disclosure/redaction.

Direct peers

  • TrialScope (Norstella): TrialScope provides clinical trial disclosure, transparency, and data-sharing solutions to sponsors and CROs, competing with RLS in the EMA/FDA disclosure and trial registration space.
  • d-wise: d-wise provides clinical data standards, analytics, and anonymization services for life sciences R&D, sharing RLS's focus on CDISC-aligned clinical trial data and regulatory submission support.
  • Privacy Analytics (IQVIA): Acquired by IQVIA, Privacy Analytics provides health data de-identification and anonymization software for clinical trials and health data sharing — directly comparable to RLS Protect's quantitative risk-based anonymization capability.
  • SHYFT Analytics (Veeva): SHYFT was acquired by Veeva and provides clinical and commercial data analytics including disclosure and transparency solutions for pharma, overlapping with RLS's regulatory disclosure focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Real Life Sciences social profiles

Digital presence

Real Life Sciences compliance and trust

Trust signal

Compliance2 records

Real Life Sciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Real Life Sciences leadership team

Management profile

Number of profiles

Profiles9 records

Real Life Sciences subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Real Life Sciences funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Real Life Sciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Real Life Sciences

What does Real Life Sciences do?

Real Life Sciences develops and sells the RLS Protect SaaS platform for clinical trial data anonymization and document redaction, supporting pharmaceutical sponsors and CROs in complying with global transparency regulations including EMA Policy 0070, Health Canada PRCI, EMA (EU) 536/2014/CTIS, and FDA disclosures. The platform combines NLP-based quantitative risk modeling, document redaction, and confidential information management, and is paired with Anonymization Services (managed service delivery) and the RLS Reveal real-world evidence discovery platform. The portfolio serves clients ranging from small trials to large global pharma, with over one million pages and thousands of datasets processed to date.

Is Real Life Sciences a public or private company?

Real Life Sciences is a private company. It is classified as corporate owned and is currently acquired.

When was Real Life Sciences founded?

Real Life Sciences was founded in 2018. It employs 51 to 100 people.

Where is Real Life Sciences based?

Real Life Sciences is headquartered in Wayne, United States, in the North America region.

How does Real Life Sciences make money?

Three revenue lines are on record. SaaS Subscription (RLS Protect) is the primary driver. The others are anonymization Services and professional Services.

Who are Real Life Sciences's main competitors?

Broad incumbents on record are Veeva Systems and Oracle Health Sciences. Direct peers are TrialScope (Norstella), d-wise, Privacy Analytics (IQVIA) and SHYFT Analytics (Veeva).

Does Real Life Sciences have an API?

No public API is recorded for Real Life Sciences.

What industry is Real Life Sciences in?

Real Life Sciences's product category is Clinical Trial Disclosure & Data Anonymization Software. Its primary akta.pro industry code is HLACAOAM, Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms, with a secondary code of HLAGAAAK, Real-World Evidence (RWE), HEOR & Epidemiology CROs. Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
citybizMediSpend Acquires Real Life SciencesMediSpend acquired Real Life Sciences, a provider of anonymization and redaction solutions for clinical trial data. The acquisition, MediSpend's second in under a year, expands its governance, risk, and compliance offerings. RLS Protect enables companies to disclose clinical data while protecting participant privacy and confidential information.VenturecapitalMediSpend Acquires Real Life Sciences to Enhance Compliance Solutions for Life Sciences IndustryMediSpend acquired Real Life Sciences, a provider of anonymization and redaction solutions for clinical trial data. The acquisition strengthens MediSpend's GRC capabilities, enabling life sciences companies to disclose trial results while protecting participant privacy and intellectual property. RLS Protect addresses compliance requirements from major regulatory bodies including EMA, FDA, and Health Canada.PR NewswireMediSpend Expands Its Footprint in Governance, Risk and Compliance Solutions with Acquisition of Real Life SciencesMediSpend acquired Real Life Sciences, a provider of anonymization and redaction solutions for clinical trial data. The acquisition expands MediSpend's governance, risk, and compliance offerings, with RLS Protect enabling disclosure of clinical data while protecting participant privacy and intellectual property.RlsciencesReal Life Sciences Acquired By MedispendMediSpend acquired Real Life Sciences, a provider of anonymization and redaction solutions for clinical trial data. The acquisition expands MediSpend's governance, risk, and compliance offerings, with RLS Protect enabling compliant disclosure while protecting participant privacy. The deal is MediSpend's second acquisition in under a year.PR NewswireThe Top Companies Racing to Keep up With the Demands of the Cannabis IndustryMultiple cannabis companies announced operational developments as the global cannabis market projects growth to $57 billion by 2027, driven by rising demand for CBD and health-related cannabis products. CannaOne Technologies Inc. entered into a Letter of Intent to acquire 100% interest in Real Life Sciences Inc., its managing partner for the BWell CBD online marketplace. Canopy Growth received a Health Canada license for its KeyLeaf extraction facility in Saskatchewan with capacity to process 5,000 kilograms of biomass daily, while Aurora Cannabis completed its acquisition of Hempco Food and Fiber for approximately C$63.4 million to secure low-cost hemp material for CBD extraction.PR NewswireCannaOne Technologies schließt eine Vereinbarung zum Erwerb von 100% der Anteile an Real Life Sciences Inc. und dem BWell US CBD Marketplace ab.CannaOne Technologies Inc. has signed a Letter of Intent to acquire 100% of Real Life Sciences Inc., which managed the BWell US CBD Marketplace, for 2,000,000 CAD paid entirely in shares at a 20% discount to market price. The transaction, scheduled to close on October 25, 2019, consolidates full ownership of the BWell marketplace under CannaOne, which had previously held a 24.9% stake as a minority partner. Real Life Sciences had served as managing partner since April 2019, contributing strategic management and business development expertise to the platform.